Table 1 Patient characteristics
LLRa (n = 64 (100%)) | OLRb (n = 64 (100%)) | p-value | |
|---|---|---|---|
Age (years) (mean ± SDc (range)) | 60.2 ± 11.2 | 59.5 ± 11.8 | 0.729 |
Male gender, n(%) | 49 (76.6) | 52 (81.3) | 0.516 |
DMd, n(%) | 13 (20.3) | 16 (25.0) | 0.526 |
Hypertension, n(%) | 17 (26.6) | 22 (34.4) | 0.337 |
ESRDe, n(%) | 0 (0.0) | 0 (0.0) | 1.000 |
CCIf score, median (IQRg) | 5 (2.7) | 6 (2.7) | 0.162 |
ECOGh ≧ 2 | 5 (7.8) | 3 (4.7) | 0.718 |
Smoking, n(%) | 16 (25.0) | 24 (37.5) | 0.127 |
Alcohol, n(%) | 13 (20.3) | 18 (28.1) | 0.302 |
BMI (kg/m2)i (mean ± SDc) | 24.9 ± 3.5 | 24.4 ± 3.3 | 0.441 |
Obesity, n(%) | 15 (23.4) | 15 (23.4) | 1.000 |
Sarcopenia (pre-operative), n(%) | 24 (37.5) | 23 (35.9) | 0.855 |
Previous abdominal surgery, n(%) | 6 (9.4) | 8 (12.5) | 0.571 |
Preoperative treatment to HCC, n(%) | 5 (7.8) | 11 (17.2) | 0.180 |
Child-Pugh class, n(%) | |||
 Class A | 64 (100) | 64 (100) | 1.000 |
BCLC stage, n(%) | 1.000 | ||
 Stage 0 | 11 (17.2) | 12 (18.8) | |
 Stage A | 51 (79.7) | 51 (79.7) | |
 Stage B | 2 (3.1) | 1 (1.6) | |
Preoperative ascites (n(%)) | 3 (4.7) | 2 (3.1) | 1.000 |
HBV infection, n(%) | 37 (57.8) | 43 (67.2) | 0.273 |
HCV infection, n(%) | 19 (29.7) | 18 (28.1) | 0.845 |
Liver cirrhosis, n(%) | 27 (42.2) | 36 (56.3) | 0.157 |
Fatty liver, n(%) | 31 (48.4) | 27 (42.2) | 0.478 |
Albumin (g/dL) (mean ± SDc) | 4.20 ± 0.40 | 4.19 ± 0.41 | 0.533 |
Hemoglobin (gm/dL) (mean ± SDc) | 13.7 ± 1.6 | 13.9 ± 1.7 | 0.503 |
NLRj, median (IQRg) | 1.83 (0.98) | 1.88 (0.85) | 0.898 |
Platelet count (K/uL) (mean ± SDc) | 174.7 ± 48.3 | 160.7 ± 53.8 | 0.121 |
T-bil (mg/dL), median (IQRg) | 0.6 (0.5) | 0.6 (0.5) | 0.266 |
INRk (mean ± SDc) | 1.1 (0.1) | 1.1 (0.11) | 0.370 |
ICG-15l > 10%, n(%) | 20 (32.3) | 21 (32.8) | 0.947 |
α-Fetoprotein > 200 ng/mL, n(%) | 15 (24.6) | 11 (17.2) | 0.308 |